Dana Rathkopf describes phase 1 data for the androgen receptor ligand-directed degrader in prostate cancer

Episode 300: Adjuvant PD1 Therapy in Solid Tumours

Broadcasting the latest developments in GU cancer

Hosted by Brian Rini and Tom Powles 

Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London